Exendin-3 (9-39) is a potent and selective GLP-1 receptor antagonist.
L Baggio; T J Kieffer; D J Drucker. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, regulates fasting glycemia and nonenteral glucose clearance in mice. Endocrinology, 2000,141(10), 3703-3709.
C M Edwards; J F Todd, M Mahmoudi; Z Wang; R M Wang; M A Ghatei; S R Bloom. Glucagon-like peptide 1 has a physiological role in the control of postprandial glucose in humans: studies with the antagonist exendin 9-39. Diabetes, 1999,48(1), 86-93.